BR112015010194A2 - sequência de ácido nucleico, análogo de insulina de cadeia única e uso do mesmo na fabricação de um medicamento para reduzir a taxa de açúcar no sangue - Google Patents
sequência de ácido nucleico, análogo de insulina de cadeia única e uso do mesmo na fabricação de um medicamento para reduzir a taxa de açúcar no sangueInfo
- Publication number
- BR112015010194A2 BR112015010194A2 BR112015010194A BR112015010194A BR112015010194A2 BR 112015010194 A2 BR112015010194 A2 BR 112015010194A2 BR 112015010194 A BR112015010194 A BR 112015010194A BR 112015010194 A BR112015010194 A BR 112015010194A BR 112015010194 A2 BR112015010194 A2 BR 112015010194A2
- Authority
- BR
- Brazil
- Prior art keywords
- medicament
- manufacture
- nucleic acid
- acid sequence
- blood sugar
- Prior art date
Links
- 108091028043 Nucleic acid sequence Proteins 0.000 title 1
- 239000008280 blood Substances 0.000 title 1
- 210000004369 blood Anatomy 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical class N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 1
- 239000004026 insulin derivative Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 150000007523 nucleic acids Chemical group 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261722350P | 2012-11-05 | 2012-11-05 | |
| US61/722,350 | 2012-11-05 | ||
| PCT/US2013/068585 WO2014071405A2 (en) | 2012-11-05 | 2013-11-05 | Long-acting single-chain insulin analogues |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112015010194A2 true BR112015010194A2 (pt) | 2017-12-12 |
| BR112015010194B1 BR112015010194B1 (pt) | 2022-03-22 |
Family
ID=50628271
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112015010194-1A BR112015010194B1 (pt) | 2012-11-05 | 2013-11-05 | Análogo de insulina de cadeia única, sequência de ácido nucleico e uso do mesmo |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US9499600B2 (pt) |
| EP (1) | EP2914620B1 (pt) |
| JP (1) | JP6584953B2 (pt) |
| KR (1) | KR102163936B1 (pt) |
| CN (2) | CN105008395B (pt) |
| AU (1) | AU2013337250B2 (pt) |
| BR (1) | BR112015010194B1 (pt) |
| CA (1) | CA2890719C (pt) |
| EA (1) | EA201590882A1 (pt) |
| ES (1) | ES2694418T3 (pt) |
| IL (1) | IL238651B (pt) |
| MX (1) | MX2015005662A (pt) |
| PH (1) | PH12015500989A1 (pt) |
| SG (1) | SG11201503522RA (pt) |
| WO (1) | WO2014071405A2 (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9624287B2 (en) | 2012-07-17 | 2017-04-18 | Case Western Reserve University | O-linked carbohydrate-modified insulin analogues |
| WO2014015078A1 (en) * | 2012-07-17 | 2014-01-23 | Michael Weiss | O-linked carbohydrate-modified insulin analogues |
| AU2015204491B2 (en) | 2014-01-13 | 2021-01-07 | Thermalin Inc. | Rapid action insulin formulations and pharmaceutical delivery systems |
| CZ308383B6 (cs) * | 2014-06-30 | 2020-07-15 | Ústav Organické Chemie A Biochemie Akademie Věd Čr, V.V.I. | Derivát inzulinu s cyklickou strukturou v C-konci B-řetězce |
| CA2961037A1 (en) * | 2014-10-06 | 2016-04-14 | Case Western Reserve University | Biphasic single-chain insulin analogues |
| AR105616A1 (es) | 2015-05-07 | 2017-10-25 | Lilly Co Eli | Proteínas de fusión |
| KR20180097517A (ko) | 2015-12-23 | 2018-08-31 | 케이스 웨스턴 리저브 유니버시티 | 매우 안정된 인슐린 유사체의 중합체 용융물 내 캡슐화 |
| JP2022507627A (ja) * | 2018-11-19 | 2022-01-18 | ケース ウェスタン リザーブ ユニバーシティ | ポリ－アラニンｃ－ドメインのサブセグメントを有する単鎖インスリンアナログ |
| CN113423691A (zh) | 2018-12-11 | 2021-09-21 | 赛诺菲 | 肽结合剂 |
| JP2022542301A (ja) | 2019-07-31 | 2022-09-30 | イーライ リリー アンド カンパニー | リラキシン類似体およびその使用方法 |
| CN114867743A (zh) * | 2019-12-10 | 2022-08-05 | 赛诺菲 | 形成磺酰胺与多肽的缀合物的方法 |
| CN118201954A (zh) | 2021-09-20 | 2024-06-14 | 克云生物科技股份公司 | 精氨酸酶-胰岛素融合蛋白 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100449454B1 (ko) * | 2000-10-02 | 2004-09-21 | 이현철 | 단일사슬 인슐린 유도체의 유전자를 포함하는 당뇨병치료용 벡터 |
| ATE270306T1 (de) * | 2000-10-02 | 2004-07-15 | Univ Yonsei Seoul | Einkettige insulinanaloge |
| WO2004096854A2 (en) * | 2003-04-29 | 2004-11-11 | Eli Lilly And Company | Insulin analogs having protracted time action |
| KR100508616B1 (ko) * | 2003-06-20 | 2005-08-17 | 신항철 | 염기성 아미노산 첨가를 통한 활성이 증가된 단일사슬 인슐린 아날로그 |
| AU2004295023A1 (en) * | 2003-12-03 | 2005-06-16 | Novo Nordisk A/S | Single-chain insulin |
| EP2074140B8 (en) * | 2006-10-04 | 2015-10-28 | Case Western Reserve University | Fibrillation-resistant insulin and insulin analogues |
| CA2722168A1 (en) * | 2008-04-22 | 2009-10-29 | Case Western Reserve University | Isoform-specific insulin analogues |
| DK2451437T3 (en) * | 2009-07-06 | 2017-02-13 | Sanofi Aventis Deutschland | Aqueous INSULIN PREPARATIONS CONTAINING METHIONIN |
| TW201105346A (en) | 2009-07-06 | 2011-02-16 | Sanofi Aventis Deutschland | Heat-stable and vibration-stable insulin preparations |
| US8399407B2 (en) | 2009-09-17 | 2013-03-19 | Case Western Reserve University | Non-standard insulin analogues |
| WO2013063572A1 (en) * | 2011-10-27 | 2013-05-02 | Case Western Reserve University | Ultra-concentrated rapid-acting insulin analogue formulations |
| CA2898730A1 (en) * | 2012-01-20 | 2013-07-25 | Case Western Reserve University | Glutamic acid-stabilized insulin analogues |
| CN104981251B (zh) * | 2012-09-26 | 2018-03-20 | 印第安纳大学研究及科技有限公司 | 胰岛素类似物二聚体 |
-
2013
- 2013-11-05 KR KR1020157014591A patent/KR102163936B1/ko active IP Right Grant
- 2013-11-05 MX MX2015005662A patent/MX2015005662A/es unknown
- 2013-11-05 ES ES13850542.5T patent/ES2694418T3/es active Active
- 2013-11-05 CA CA2890719A patent/CA2890719C/en active Active
- 2013-11-05 US US14/440,540 patent/US9499600B2/en active Active
- 2013-11-05 EP EP13850542.5A patent/EP2914620B1/en active Active
- 2013-11-05 WO PCT/US2013/068585 patent/WO2014071405A2/en active Application Filing
- 2013-11-05 BR BR112015010194-1A patent/BR112015010194B1/pt not_active IP Right Cessation
- 2013-11-05 EA EA201590882A patent/EA201590882A1/ru unknown
- 2013-11-05 AU AU2013337250A patent/AU2013337250B2/en active Active
- 2013-11-05 CN CN201380069346.0A patent/CN105008395B/zh not_active Expired - Fee Related
- 2013-11-05 JP JP2015541857A patent/JP6584953B2/ja active Active
- 2013-11-05 CN CN202010947063.3A patent/CN112266414A/zh active Pending
- 2013-11-05 SG SG11201503522RA patent/SG11201503522RA/en unknown
-
2015
- 2015-05-05 IL IL238651A patent/IL238651B/en active IP Right Grant
- 2015-05-05 PH PH12015500989A patent/PH12015500989A1/en unknown
-
2016
- 2016-11-22 US US15/358,977 patent/US9975940B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2014071405A3 (en) | 2014-08-21 |
| MX2015005662A (es) | 2015-08-20 |
| US9975940B2 (en) | 2018-05-22 |
| WO2014071405A2 (en) | 2014-05-08 |
| CN105008395B (zh) | 2020-12-29 |
| US20150274803A1 (en) | 2015-10-01 |
| CA2890719A1 (en) | 2014-05-08 |
| PH12015500989A1 (en) | 2015-07-13 |
| CN105008395A (zh) | 2015-10-28 |
| IL238651A0 (en) | 2015-06-30 |
| JP6584953B2 (ja) | 2019-10-02 |
| CN112266414A (zh) | 2021-01-26 |
| IL238651B (en) | 2020-03-31 |
| AU2013337250B2 (en) | 2017-06-22 |
| EP2914620B1 (en) | 2018-08-08 |
| JP2016506366A (ja) | 2016-03-03 |
| CA2890719C (en) | 2023-02-14 |
| US20170137488A1 (en) | 2017-05-18 |
| BR112015010194B1 (pt) | 2022-03-22 |
| KR102163936B1 (ko) | 2020-10-13 |
| ES2694418T3 (es) | 2018-12-20 |
| US9499600B2 (en) | 2016-11-22 |
| EP2914620A4 (en) | 2016-05-25 |
| EA201590882A1 (ru) | 2015-09-30 |
| KR20150096387A (ko) | 2015-08-24 |
| EP2914620A2 (en) | 2015-09-09 |
| SG11201503522RA (en) | 2015-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112015010194A2 (pt) | sequência de ácido nucleico, análogo de insulina de cadeia única e uso do mesmo na fabricação de um medicamento para reduzir a taxa de açúcar no sangue | |
| BR112014021103A8 (pt) | anticorpo, composição farmacêutica, droga de combinação, dna, método de tratamento e uso de anticorpo | |
| BR112015003332A2 (pt) | composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente | |
| BR112015003397A2 (pt) | composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente. | |
| BR112015003398A2 (pt) | composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente | |
| DK2641614T3 (da) | Farmaceutisk præparat integreret med mikronåle til hudbehandling | |
| EP2718317A4 (en) | GLUCOSE-DEPENDENT INSULINOTROPE POLYPEPTIDE ANALOGUE, PHARMACEUTICAL COMPOSITIONS AND THEIR USE | |
| EP2877115A4 (en) | SPECIFIC INSTRUMENT FOR A PATIENT WITH MICROELECTROMECHANICAL SYSTEM FOR USE IN SURGERY | |
| EP2825227A4 (en) | DISPOSABLE INJECTION PEN MULTIPLE PURPOSE | |
| BR112015002541A2 (pt) | composto, composição farmacêutica, uso de um composto, e, método para tratamento de hcv em um paciente. | |
| BR112013023732A2 (pt) | caneta de injeção descartável para múltiplos usos | |
| EP2881395A4 (en) | PIPERAZINOTRIZOLE COMPOUND, PROCESS FOR PREPARING THE SAME AND USE THEREOF IN THE PREPARATION OF MEDICAMENT | |
| AU2014322046A1 (en) | Complex containing oligonucleotide having immunopotentiating activity and use thereof | |
| BR112015001457A8 (pt) | formulação líquida de conjugado de insulina de ação prolongada. | |
| HK1196267A1 (en) | Pharmaceutical combination for use in glycemic control in diabetes type patients | |
| SG10201802199TA (en) | Complex containing oligonucleotide having immunopotentiating activity and use thereof | |
| BR112013022556A8 (pt) | composição farmacêutica aquosa semissólida contendo tapentadol, seu uso e uso de tapentadol | |
| BR112015006525A2 (pt) | dispositivo de infusão descartável, e uso de um dispositivo de infusão descartável | |
| BR112014026557A2 (pt) | fralda descartável. | |
| HK1204056A1 (zh) | 血糖儀 | |
| EP2865666A4 (en) | HEXAHYDROPENTALENE DERIVATIVES, METHOD OF MANUFACTURE AND USE IN MEDICINE | |
| BR112015007150A2 (pt) | ligante de env anti-herv-w, droga inibidora de radil óxido nítrico, composição farmacêutica, método e produto farmacêutico | |
| HK1220150A1 (zh) | 注射器標簽以及採用注射器標籤的可注入醫藥溶劑式注射器 | |
| HK1249848A1 (zh) | 親脂性物質的水溶液，特別是藥物物質溶液 | |
| BR112014028620A2 (pt) | ponta de cateter de infusão para materiais biológicos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 05/11/2013, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 10A ANUIDADE. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2747 DE 29-08-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |